Article Versions Notes

Repici A, Hasan A, Capra AP, Scuderi SA, Paterniti I, Campolo M, Ardizzone A, Esposito E. Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers? Marine Drugs. 2024; 22(8):336. https://doi.org/10.3390/md22080336

Repici, Alberto, Ahmed Hasan, Anna Paola Capra, Sarah Adriana Scuderi, Irene Paterniti, Michela Campolo, Alessio Ardizzone, and Emanuela Esposito. 2024. "Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?" Marine Drugs 22, no. 8: 336. https://doi.org/10.3390/md22080336

Repici, A., Hasan, A., Capra, A. P., Scuderi, S. A., Paterniti, I., Campolo, M., Ardizzone, A., & Esposito, E. (2024). Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers? Marine Drugs, 22(8), 336. https://doi.org/10.3390/md22080336